Table 3.
Metabolite ratios (95% confidence interval) within the T2L between newly diagnosed and recurrent patients.
| Newly-Diagnosed (N=12) | Recurrent (N=16) | P-value | |
|---|---|---|---|
| tCho/tCr | 0.24–0.31 | 0.26–0.34 | 0.5070 |
| NAA/tCr | 1.20–1.45 | 0.98–1.26 | 0.1330 |
| tCho/NAA | 0.18–0.24 | 0.22–0.37 | 0.1457 |
| Glu/tCr | 0.91–1.26 | 0.91–1.09 | 0.5070 |
| Gln/tCr | 0.56–1.00 (N = 7) | 0.66–1.00 (N = 15) | 0.8601 |
| Glx/tCr | 1.07–1.66 (N = 11) | 1.25–1.54 | 0.4155 |
| GSH/tCr | 0.26–0.37 | 0.29–0.36 | 0.2601 |
| mI/tCr | 0.77–1.11 | 0.89–1.19 | 0.6313 |
| Gly/tCr | 0.26–0.45 (N = 11) | 0.27–0.37 | 0.6569 |
| mIG/tCr | 0.91–1.27 | 1.00–1.25 | 0.9091 |
| mI/tCho | 2.85–4.48 | 2.95–4.57 | 0.9091 |
| GABA/tCr | 0.45–0.57 (N = 8) | 0.48–0.56 (N = 11) | 0.9039 |
N = number of patients.